320 related articles for article (PubMed ID: 27019462)
1. Clinical Features and Management of Congenital Fibrinogen Deficiencies.
Casini A; de Moerloose P; Neerman-Arbez M
Semin Thromb Hemost; 2016 Jun; 42(4):366-74. PubMed ID: 27019462
[TBL] [Abstract][Full Text] [Related]
2. Congenital fibrinogen disorders: an update.
de Moerloose P; Casini A; Neerman-Arbez M
Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
[TBL] [Abstract][Full Text] [Related]
3. Can the phenotype of inherited fibrinogen disorders be predicted?
Casini A; de Moerloose P
Haemophilia; 2016 Sep; 22(5):667-75. PubMed ID: 27293018
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and treatment of congenital fibrinogen deficiency.
Peyvandi F
Thromb Res; 2012 Dec; 130 Suppl 2():S7-11. PubMed ID: 23439004
[TBL] [Abstract][Full Text] [Related]
5. Congenital structural and functional fibrinogen disorders: a primer for internists.
Undas A; Casini A
Pol Arch Intern Med; 2019 Dec; 129(12):913-920. PubMed ID: 31797863
[TBL] [Abstract][Full Text] [Related]
6. Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.
Casini A; Abdul Kadir R; Abdelwahab M; Manco-Johnson MJ; Raut S; Ross C; de Moerloose P; Santoro C; Acharya S
J Thromb Haemost; 2024 May; 22(5):1516-1521. PubMed ID: 38266678
[TBL] [Abstract][Full Text] [Related]
7. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations.
Wypasek E; Klukowska A; Zdziarska J; Zawilska K; Treliński J; Iwaniec T; Mital A; Pietrys D; Sydor W; Neerman-Arbez M; Undas A
Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941
[TBL] [Abstract][Full Text] [Related]
8. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
Neerman-Arbez M; de Moerloose P; Casini A
Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
[TBL] [Abstract][Full Text] [Related]
9. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management.
Casini A; Neerman-Arbez M; Ariëns RA; de Moerloose P
J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717
[TBL] [Abstract][Full Text] [Related]
10. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation.
Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P
J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264
[TBL] [Abstract][Full Text] [Related]
11. How I treat dysfibrinogenemia.
Casini A; de Moerloose P
Blood; 2021 Nov; 138(21):2021-2030. PubMed ID: 33895794
[TBL] [Abstract][Full Text] [Related]
12. Rare inherited disorders of fibrinogen.
Acharya SS; Dimichele DM
Haemophilia; 2008 Nov; 14(6):1151-8. PubMed ID: 19141154
[TBL] [Abstract][Full Text] [Related]
13. Women With Congenital Hypofibrinogenemia/Afibrinogenemia: From Birth to Death.
Zhang Y; Zuo X; Teng Y
Clin Appl Thromb Hemost; 2020; 26():1076029620912819. PubMed ID: 32233805
[TBL] [Abstract][Full Text] [Related]
14. Congenital fibrinogen disorders.
de Moerloose P; Neerman-Arbez M
Semin Thromb Hemost; 2009 Jun; 35(4):356-66. PubMed ID: 19598064
[TBL] [Abstract][Full Text] [Related]
15. Congenital fibrinogen disorders with repeated thrombosis.
Zhang X; Zhang C; Wang B; Chen N; Sun G; Guo X
J Thromb Thrombolysis; 2020 Feb; 49(2):312-315. PubMed ID: 31542854
[TBL] [Abstract][Full Text] [Related]
16. Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.
Mohsenian S; Palla R; Menegatti M; Cairo A; Lecchi A; Casini A; Neerman-Arbez M; Asselta R; Scardo S; Siboni SM; Blatny J; Zapletal O; Schved JF; Giansily-Blaizot M; Halimeh S; Daoud MA; Platokouki H; Pergantou H; Schutgens REG; Van Haaften-Spoor M; Brons P; Laros-van Gorkom B; Van Pinxten E; Borhany M; Fatima N; Mikovic D; Saracevic M; Özdemir GN; Ay Y; Makris M; Lockley C; Mumford A; Harvey A; Austin S; Shapiro A; Williamson A; McGuinn C; Goldberg I; De Moerloose P; Peyvandi F
Blood Adv; 2024 Mar; 8(6):1392-1404. PubMed ID: 38286442
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management.
Casini A; Neerman-Arbez M; de Moerloose P
Blood Rev; 2021 Jul; 48():100793. PubMed ID: 33419567
[TBL] [Abstract][Full Text] [Related]
18. Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders.
Castaman G; Giacomelli SH; Biasoli C; Contino L; Radossi P
Eur J Haematol; 2019 Oct; 103(4):379-384. PubMed ID: 31314131
[TBL] [Abstract][Full Text] [Related]
19. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
[TBL] [Abstract][Full Text] [Related]
20. Management of dysfibrinogenemia in pregnancy: A case report.
Yan J; Deng D; Cheng P; Liao L; Luo M; Lin F
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28948631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
